BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36748641)

  • 1. Genomic characterization of colistin resistance in
    Chen X; Sun Z; Xu X; Jiang J; Su J
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748641
    [No Abstract]   [Full Text] [Related]  

  • 2. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
    Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
    Hu H; Shi Q; Zhang P; Quan J; Han X; Zhao D; Zhang H; Wang Q; Jiang Y; Yu Y
    Int J Antimicrob Agents; 2023 Aug; 62(2):106873. PubMed ID: 37276893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Colistin Resistance Among Klebsiella Pneumoniae Strains.
    Borsa BA; Demirci M; Gungordu-Dalar Z; Karabiyik G; Aygun G; Kucukbasmaci O
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
    Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
    Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
    Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Noori Goodarzi N; Solgi H; Badmasti F
    Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):74. PubMed ID: 34688302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin Resistance Mechanisms in Clinical
    Snyman Y; Whitelaw AC; Reuter S; Maloba MRB; Newton-Foot M
    Microb Drug Resist; 2021 Sep; 27(9):1249-1258. PubMed ID: 33571049
    [No Abstract]   [Full Text] [Related]  

  • 10. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
    Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
    J Glob Antimicrob Resist; 2022 Sep; 30():357-362. PubMed ID: 35817263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms.
    Torres DA; Seth-Smith HMB; Joosse N; Lang C; Dubuis O; Nüesch-Inderbinen M; Hinic V; Egli A
    BMC Microbiol; 2021 Nov; 21(1):321. PubMed ID: 34798825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of different colistin resistance mechanisms among multidrug resistant Klebsiella pneumoniae isolates in Bulgaria.
    Markovska R; Marteva-Proevska Y; Velinov T; Pavlov I; Kaneva R; Boyanova L
    Acta Microbiol Immunol Hung; 2022 Sep; 69(3):220-227. PubMed ID: 35895482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways Regulating the pbgP Operon and Colistin Resistance in Klebsiella pneumoniae Strains.
    Choi MJ; Kim S; Ko KS
    J Microbiol Biotechnol; 2016 Sep; 26(9):1620-8. PubMed ID: 27238937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Kim SJ; Ko KS
    Int J Antimicrob Agents; 2018 Sep; 52(3):425-429. PubMed ID: 29944953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
    Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
    J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of colistin-resistant
    Shankar C; Venkatesan M; Rajan R; Mani D; Lal B; Prakash JAJ; Anandan S; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
    Indian J Med Res; 2019 Feb; 149(2):199-207. PubMed ID: 31219084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Huang PH; Chen WY; Chou SH; Wang FD; Lin YT
    Microbiol Spectr; 2022 Jun; 10(3):e0038122. PubMed ID: 35652641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phylogenomic approach for the analysis of colistin resistance-associated genes in Klebsiella pneumoniae, its mutational diversity and implications for phenotypic resistance.
    Elias R; Spadar A; Phelan J; Melo-Cristino J; Lito L; Pinto M; Gonçalves L; Campino S; Clark TG; Duarte A; Perdigão J
    Int J Antimicrob Agents; 2022 Jun; 59(6):106581. PubMed ID: 35378228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.